Company / Revenue
Immunocore Holdings plc Revenue History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$400.0M
FY2025
5-year range
$36.5M / $400.0M
FY2021-FY2025
Trend
+29.0%
vs FY2024
Sector context
#72 of 155
Health Care
What the data says
At $400M, Immunocore Holdings plc's revenue ranks #72 of 155 in the Health Care sector. Revenue has increased for 4 consecutive years, from $36M in FY2021 to $400M in FY2025.
Based on SEC 10-K filings.
$400M in FY2025 with a 3-year CAGR of +31.9%.
Improved from $249M to $400M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +31.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#72 of 155 in Health CareTop 46% of 155This company $400.0M Sector average $4.5B
▼
-91.1% below sector average
Key checks
Key Insights
- Immunocore Holdings plc's revenue has grown for 4 consecutive years.
- 3-year CAGR of +31.9%, indicating consistent growth.
- In FY2025, revenue increased 29.0% year-over-year.
- Ranks #72 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $400.0M | +29.0% |
| FY2024 | $310.2M | +24.4% |
| FY2023 | $249.4M | +43.1% |
| FY2022 | $174.4M | +377.9% |
| FY2021 | $36.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026